Skip to Content
Merck
CN

Key Documents

View All Documentation

479306

cis-Diamineplatinum(II) dichloride

≥99.9% trace metals basis

Synonym(s):

cis-Diammineplatinum(II) dichloride, cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cisplatin

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
Pt(NH3)2Cl2
CAS Number:
15663-27-1
Molecular Weight:
300.05
NACRES:
NA.22
PubChem Substance ID:
24871609
UNSPSC Code:
12161600
EC Number:
239-733-8
MDL number:
MFCD00011623
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥99.9% trace metals basis

reaction suitability

core: platinum, reagent type: catalyst

mp

270 °C (lit.)

antibiotic activity spectrum

neoplastics

mode of action

DNA synthesis | interferes

SMILES string

N.N.Cl[Pt]Cl

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

InChI key

LXZZYRPGZAFOLE-UHFFFAOYSA-L

Application

cis-Diamineplatinum(II) dichloride can be used as a model drug to test the efficiency of various drug carriers in drug delivery.
Highly active chemotherapeutic agent for use in preventing the advancement of testicular cancer.

Biochem/physiol Actions

Potent platinum-based antineoplastic agent. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links.

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

target_organs

Respiratory system

Storage Class

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Hazard Classifications

Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Repr. 1B - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCQ0910
MKCM4090
MKCL3343
MKCK9497
MKCK5299

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis of a new nanoparticle system based on electrostatic alginate?piperazine interactions.
Roman JV, et al.
Polymers For Advanced Technologies, 27(5), 623-629 (2016)
Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy.
Xu P, et al.
Colloids and Surfaces. B, Biointerfaces, 48(1), 50-57 (2006)
Pedro J Beltran et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2947-2958 (2014-04-15)
Insulin-like growth factor 1 receptor (IGF-IR) has been implicated in the pathogenesis of ovarian cancer. Ganitumab is an investigational, fully human monoclonal antibody against IGF-IR. Here, we explore the therapeutic potential of ganitumab for the treatment of ovarian cancer. The
View All Related Papers

Global Trade Item Number

SKUGTIN
479306-50G04061833411339
479306-1G04061835555208
479306-5G04061832373287